Related references
Note: Only part of the references are listed.Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
Valeria Melisa et al.
BEHAVIOURAL PHARMACOLOGY (2015)
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
Charles R. Harrington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Distinct Therapeutic Mechanisms of Tau Antibodies PROMOTING MICROGLIAL CLEARANCE VERSUS BLOCKING NEURONAL UPTAKE
Kristen E. Funk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells
Marija Usenovic et al.
JOURNAL OF NEUROSCIENCE (2015)
Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease
Hua Zhang et al.
JOURNAL OF NEUROSCIENCE (2015)
The microtubule-stabilizing drug Epothilone D increases axonal sprouting following transection injury in vitro
Mariana Brizuela et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes
Nataliya Golovyashkina et al.
MOLECULAR NEURODEGENERATION (2015)
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
Sang-Won Min et al.
NATURE MEDICINE (2015)
Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice
Meaghan Morris et al.
NATURE NEUROSCIENCE (2015)
Tau immunization: a cautionary tale?
Alexandra J. Mably et al.
NEUROBIOLOGY OF AGING (2015)
Systemic administration of epothilone B promotes axon regeneration after spinal cord injury
Joerg Ruschel et al.
SCIENCE (2015)
Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss
J. H. Birnbaum et al.
CELL DEATH & DISEASE (2015)
Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders
Vladimir N. Uversky
FRONTIERS IN AGING NEUROSCIENCE (2015)
Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies
Chun-ling Dai et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
Sethu Sankaranarayanan et al.
PLOS ONE (2015)
Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer's Disease
Thomas C. Baddeley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
A Refined Reaction-Diffusion Model of Tau-Microtubule Dynamics and Its Application in FDAP Analysis
Maxim Igaev et al.
BIOPHYSICAL JOURNAL (2014)
RNA Protein Granules Modulate tau Isoform Expression and Induce Neuronal Sprouting
Katharina Moschner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Aβ1-42 peptide regulates microtubule stability independently of tau
Barbara Pianu et al.
JOURNAL OF CELL SCIENCE (2014)
Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
Diana L. Castillo-Carranza et al.
JOURNAL OF NEUROSCIENCE (2014)
Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging
Qiu-Lan Ma et al.
JOURNAL OF NEUROSCIENCE (2014)
Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons
Dennis Janning et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
Adam L. Boxer et al.
LANCET NEUROLOGY (2014)
L-type Ca2+ currents at CA1 synapses, but not CA3 or dentate granule neuron synapses, are increased in 3xTgAD mice in an age-dependent manner
Yue Wang et al.
NEUROBIOLOGY OF AGING (2014)
NEURONAL DEGENERATION, SYNAPTIC DEFECTS, AND BEHAVIORAL ABNORMALITIES IN TAU45-230 TRANSGENIC MICE
A. E. Lang et al.
NEUROSCIENCE (2014)
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Protein phosphatase 2A dysfunction in Alzheimer's disease
Jean-Marie Sontag et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
Iddo Magen et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
Bruce H. Morimoto et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Successes and Failures for Drugs in Late-Stage Development for Alzheimer's Disease
Camryn Berk et al.
DRUGS & AGING (2013)
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy
Qin Zhihui
FUTURE MEDICINAL CHEMISTRY (2013)
Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
Alex Crowe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
Jiaping Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice
Meaghan Morris et al.
NEUROBIOLOGY OF AGING (2013)
NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport
Yan Jouroukhin et al.
NEUROBIOLOGY OF DISEASE (2013)
Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
Ji Won Um et al.
NEURON (2013)
Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: Implications for chemotherapy-induced peripheral neuropathy
Nichole E. LaPointe et al.
NEUROTOXICOLOGY (2013)
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
Clara Theunis et al.
PLOS ONE (2013)
NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss
C. Tackenberg et al.
CELL DEATH & DISEASE (2013)
Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
Erin E. Congdon et al.
AUTOPHAGY (2012)
Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-D-aspartate receptors in cortical cultures
I. L. Ferreira et al.
CELL CALCIUM (2012)
Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration
Patrizia Fanara et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Design and Synthesis of Neuroprotective Methylthiazoles and Modification as NO-Chimeras for Neurodegenerative Therapy
Zhihui Qjn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Microtubule Stabilizing Agents as Potential Treatment for Alzheimer's Disease and Related Neurodegenerative Tauopathies
Carlo Ballatore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027
Donna M. Barten et al.
JOURNAL OF NEUROSCIENCE (2012)
The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
Bin Zhang et al.
JOURNAL OF NEUROSCIENCE (2012)
Correlations between cortical and subcortical tau pathology
J. Attems et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Methylene Blue Protects against TDP-43 and FUS Neuronal Toxicity in C. elegans and D. rerio
Alexandra Vaccaro et al.
PLOS ONE (2012)
Methylene Blue Reduces Aβ Levels and Rescues Early Cognitive Deficit by Increasing Proteasome Activity
David X. Medina et al.
BRAIN PATHOLOGY (2011)
Protection Against Tauopathy by the Drug Candidates NAP (Davunetide) and D-SAL: Biochemical, Cellular and Behavioral Aspects
Natalia Shiryaev et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Illana Gozes
CURRENT PHARMACEUTICAL DESIGN (2011)
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
Elina Ronnemaa et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner
Anne Gauthier-Kemper et al.
JOURNAL OF CELL BIOLOGY (2011)
Are Tangles as Toxic as They Look?
Tara L. Spires-Jones et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Shaomin Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Effects of Amyloid-β Peptides on Voltage-Gated L-Type CaV1.2 and CaV1.3 Ca2+ Channels
Sunoh Kim et al.
MOLECULES AND CELLS (2011)
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
Mian Bi et al.
PLOS ONE (2011)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Tau Truncation is a Productive Posttranslational Modification of Neurofibrillary Degeneration in Alzheimer's Disease
B. Kovacech et al.
CURRENT ALZHEIMER RESEARCH (2010)
Tau Pathology and Future Therapeutics
I. Gozes
CURRENT ALZHEIMER RESEARCH (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
Moran Boimel et al.
EXPERIMENTAL NEUROLOGY (2010)
Activity-Dependent Neuroprotective Protein (ADNP) Expression in the Amyloid Precursor Protein/Presenilin 1 Mouse Model of Alzheimer's Disease
Rafael Fernandez-Montesinos et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
Kurt R. Brunden et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation
Hai-Yan Wu et al.
JOURNAL OF NEUROSCIENCE (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
Frauke van Bebber et al.
NEUROBIOLOGY OF DISEASE (2010)
Diabetes, Alzheimer disease, and vascular dementia A population-based neuropathologic study
S. Ahtiluoto et al.
NEUROLOGY (2010)
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Marianne Renner et al.
NEURON (2010)
LOSS OF TAU ELICITS AXONAL DEGENERATION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE
H. N. Dawson et al.
NEUROSCIENCE (2010)
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease
Clifford R. Jack et al.
BRAIN (2009)
Thin, Stubby or Mushroom: Spine Pathology in Alzheimer's Disease
C. Tackenberg et al.
CURRENT ALZHEIMER RESEARCH (2009)
Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-β, Wild-Type Tau, and R406W Tau
Christian Tackenberg et al.
JOURNAL OF NEUROSCIENCE (2009)
Increased Membrane Cholesterol Might Render Mature Hippocampal Neurons More Susceptible to β-Amyloid-Induced Calpain Activation and Tau Toxicity
Alexandra M. Nicholson et al.
JOURNAL OF NEUROSCIENCE (2009)
A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau
Roland Brandt et al.
NEUROBIOLOGY OF AGING (2009)
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies
Alessia Chiorazzi et al.
NEUROBIOLOGY OF DISEASE (2009)
Reversal of long-term dendritic spine alterations in Alzheimer disease models
Donna L. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Microtubule Binding and Trapping at the Tip of Neurites Regulate Tau Motion in Living Neurons
Carina Weissmann et al.
TRAFFIC (2009)
Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice
Aidong Yuan et al.
JOURNAL OF NEUROSCIENCE (2008)
A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease
Yasuji Matsuoka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Characterization of tau in cerebrospinal fluid using mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Alzheimer disease models and human neuropathology: similarities and differences
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2008)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis
Patrizia Fanara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
Diane P. Hanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-β in cultured cortical neurons:: evidence that tau phosphorylation is the limiting factor in amyloid-β-induced cell death
Julia Leschik et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester
Brian M. Bennett et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Amyloid β peptide adversely affects spine number and motility in hippocampal neurons
Brikha R. Shrestha et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
Hanna Rosenmann et al.
ARCHIVES OF NEUROLOGY (2006)
ERK1/2 activation mediates Aβ oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures
Young Hae Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices
Neelam Shahani et al.
JOURNAL OF NEUROSCIENCE (2006)
Disease-related modifications in tau affect the interaction between Fyn and tau
K Bhaskar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The generation of a 17 kDa neurotoxic fragment:: An alternative mechanism by which tau mediates β-amyloid-induced neurodegeneration
SY Park et al.
JOURNAL OF NEUROSCIENCE (2005)
Dendrite and dendritic spine alterations in Alzheimer models
DL Moolman et al.
JOURNAL OF NEUROCYTOLOGY (2004)
Alzheimer's missing link?
[Anonymous]
MOLECULAR THERAPY (2003)
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
TC Gamblin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Cytoskeletal mechanisms of neuronal degeneration
R Brandt
CELL AND TISSUE RESEARCH (2001)
Both total and phosphorylated tau are increased in Alzheimer's disease
M Sjögren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Proapoptotic effects of Tau cleavage product generated by caspase-3
CW Chung et al.
NEUROBIOLOGY OF DISEASE (2001)
Traumatic brain injury as a risk factor for Alzheimer's disease: A review
TC Lye et al.
NEUROPSYCHOLOGY REVIEW (2000)
Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice
S Ikegami et al.
NEUROSCIENCE LETTERS (2000)
PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons
M Rapoport et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
